Would paxalisib be a great treatment option here? Potentially, as it has a safe side effect profile and is a potent inhibitor of the PI3K/Akt/mTOR Pathway.https://www.mdpi.com/1999-4923/13/8/1195/htm
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint